Prof. Tapan Kumar Mohanta, PhD (University of Turin, Italy), FRSB, CBiol, is an elected Fellow of the Royal Society of Biology (UK), Chartered Biologist, and Professor in the Department of Genetic Research at the Institute for Medical Research and Consultation (IMRC), Imam Abdulrahman Bin Faisal University, Saudi Arabia. He is an internationally recognized scientist specializing in computational genomics, proteomics, molecular evolution, multi-omics integration, and machine learning-driven biological discovery.
Prof. Mohanta has published over 110 peer-reviewed articles, received more than 8,000 citations, and holds an H-index of 46 and i10-index above 95. He is consistently recognized among the world's top 2% most-cited researchers (Stanford) and ranked among the top 5% by SciRank Global. His pioneering research includes evidence for genetic code reduction, discovery of quadruplet anticodons, comprehensive anticodon databases, and large-scale virtual 2D proteome maps spanning plant, fungal, cyanobacterial, viral, and chloroplast proteomes. His work has also identified novel signaling motifs, WRKY transcription factors, MAPK variants, and mechanisms related to SARS-CoV-2 infection and treatment. He has held research and academic positions across Europe, Asia, and the Middle East, including Visiting Scientist at the Francis Crick Institute (UK) and Research Professor at Yeungnam University (South Korea). He contributes extensively to academic leadership, doctoral supervision
Prof. Tapan Kumar Mohanta, PhD (University of Turin, Italy), FRSB, CBiol, is an elected Fellow of the Royal Society of Biology (UK), Chartered Biologist, and Professor in the Department of Genetic Research at the Institute for Medical Research and Consultation (IMRC), Imam Abdulrahman Bin Faisal University, Saudi Arabia. He is an internationally recognized scientist specializing in computational genomics, proteomics, molecular evolution, multi-omics integration, and machine learning-driven biological discovery.
Prof. Mohanta has published over 110 peer-reviewed articles, received more than 8,000 citations, and holds an H-index of 46 and i10-index above 95. He is consistently recognized among the world's top 2% most-cited researchers (Stanford) and ranked among the top 5% by SciRank Global. His pioneering research includes evidence for genetic code reduction, discovery of quadruplet anticodons, comprehensive anticodon databases, and large-scale virtual 2D proteome maps spanning plant, fungal, cyanobacterial, viral, and chloroplast proteomes. His work has also identified novel signaling motifs, WRKY transcription factors, MAPK variants, and mechanisms related to SARS-CoV-2 infection and treatment. He has held research and academic positions across Europe, Asia, and the Middle East, including Visiting Scientist at the Francis Crick Institute (UK) and Research Professor at Yeungnam University (South Korea). He contributes extensively to academic leadership, doctoral supervision